STOCK TITAN

Rockwell Medical (RMTI) director granted 9,633 RSUs, holdings adjusted after reverse split

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nissenson Allen reported acquisition or exercise transactions in this Form 4 filing.

ROCKWELL MEDICAL, INC. director Allen Nissenson received a grant of 9,633 shares of Common Stock as a compensation award, recorded at a price of $0.0000 per share. These shares are in the form of restricted stock units that vest on July 1, 2027, subject to his continued service through the 2027 annual meeting.

The company also completed a 1-for-10 reverse split of its common stock effective 12:01 a.m. on July 1, 2026, which reduced the number of shares held and adjusted outstanding equity awards. After these changes and the grant, Nissenson beneficially owns 23,892 shares directly.

Positive

  • None.

Negative

  • None.
Insider Nissenson Allen
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 9,633 $0.00 $0.00
Holdings After Transaction: Common Stock — 23,892 shares (Direct)
Footnotes (2)
  1. F1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.
  2. F2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
RSU grant size 9,633 shares Restricted stock units granted to director Allen Nissenson
Grant price $0.0000 per share Stated price for the RSU grant
Shares after transaction 23,892 shares Beneficially owned following reported transaction(s)
Reverse split ratio 1-for-10 Reverse split of common stock effective July 1, 2026
Vesting date July 1, 2027 Vesting of restricted stock units, subject to continued service
Restricted stock units financial
"Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
reverse split financial
"the Issuer effected a 1-for-10 reverse split of the Issuer's common stock"
A reverse split is when a company reduces the number of its outstanding shares by combining several existing shares into one new share, so the price per share rises proportionally while the company’s overall value stays the same. Investors care because it can make a stock appear more respectable or meet exchange rules — like turning many small coins into a single larger bill — but it can also signal financial trouble and often affects trading liquidity and investor perception.
equity awards financial
"In addition, proportionate adjustments were made to the Issuer's outstanding equity awards."
Equity awards are payments to employees or directors made in the form of company stock or rights to buy stock later, serving as a way to share ownership rather than cash. For investors, they matter because they align staff incentives with company performance, can increase the number of shares outstanding over time (which can reduce each share’s claim on profits), and create compensation costs that affect reported earnings.
beneficially owned financial
"Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Allen Nissenson acquire in the latest Rockwell Medical (RMTI) Form 4?

Allen Nissenson received 9,633 shares of Rockwell Medical Common Stock as a grant. The award is structured as restricted stock units that were granted at a stated price of $0.0000 per share and counts toward his overall beneficial ownership position.

When do Allen Nissenson’s new Rockwell Medical (RMTI) restricted stock units vest?

The restricted stock units vest on July 1, 2027, if Nissenson continues to serve the company through the 2027 annual meeting. This ties the equity compensation to ongoing board service over a multi‑year period before the shares become fully earned.

How many Rockwell Medical (RMTI) shares does Allen Nissenson own after this Form 4?

Following the reported grant and reverse split adjustment, Allen Nissenson beneficially owns 23,892 shares of Rockwell Medical Common Stock directly. This figure reflects both his prior holdings and the impact of the 1‑for‑10 reverse stock split on his equity position.

What reverse stock split did Rockwell Medical (RMTI) implement affecting this Form 4?

Rockwell Medical effected a 1‑for‑10 reverse split of its common stock effective 12:01 a.m. on July 1, 2026. This reduced the number of shares outstanding and proportionately adjusted existing equity awards, including the amounts reported as beneficially owned by Allen Nissenson.

Is Allen Nissenson’s Rockwell Medical (RMTI) Form 4 a market purchase or a grant?

The transaction is a grant, coded as an “A” transaction for a grant, award, or other acquisition. Nissenson did not buy shares in the open market; instead he received 9,633 restricted stock units as part of his equity compensation package.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nissenson Allen

(Last)(First)(Middle)
C/O ROCKWELL MEDICAL, INC.
30142 WIXOM ROAD

(Street)
WIXOM MICHIGAN 48393

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026A(1)9,633A$023,892(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.
2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Remarks:
/s/ Megan Timmins, Attorney-in-Fact for Allen R. Nissenson07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)